1. Home
  2. NKTX vs FBIO Comparison

NKTX vs FBIO Comparison

Compare NKTX & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.09

Market Cap

132.8M

Sector

Health Care

ML Signal

HOLD

Logo Fortress Biotech Inc.

FBIO

Fortress Biotech Inc.

HOLD

Current Price

$4.40

Market Cap

113.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
FBIO
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.8M
113.9M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
NKTX
FBIO
Price
$2.09
$4.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$13.25
$16.50
AVG Volume (30 Days)
708.2K
785.2K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$62,303,000.00
Revenue This Year
N/A
$29.71
Revenue Next Year
N/A
$49.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$1.33
52 Week High
$2.74
$4.53

Technical Indicators

Market Signals
Indicator
NKTX
FBIO
Relative Strength Index (RSI) 69.68 78.81
Support Level $1.79 $4.02
Resistance Level $2.22 $4.34
Average True Range (ATR) 0.08 0.23
MACD 0.04 0.06
Stochastic Oscillator 75.73 88.89

Price Performance

Historical Comparison
NKTX
FBIO

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: